本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Allogene Therapeutics Inc.

2.50
+0.430020.77%
成交量:509.34萬
成交額:1,221.13萬
市值:6.09億
市盈率:-2.89
高:2.53
開:2.14
低:2.13
收:2.07
52周最高:2.80
52周最低:0.8621
股本:2.44億
流通股本:1.68億
量比:1.83
換手率:3.03%
股息:- -
股息率:- -
每股收益(TTM):-0.8652
每股收益(LYR):-0.8652
淨資產收益率:-53.42%
總資產收益率:-26.82%
市淨率:2.08
市盈率(LYR):-2.89

資料載入中...

2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/12

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/12

重要事件披露

Form 8-K - Current report
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/10/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/11

重要事件披露

Form 8-K - Current report
2025/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/13

重要事件披露

Form 8-K - Current report